Pfizer Ltd reported a strong Q3 performance with double-digit revenue growth, sharp expansion in EBITDA and margin. Previous Post Adani Enterprises sets February 13 as record date for final rights issue payment Next Post Aurobindo Pharma Q3 Results: Net profit up 8% on Europe, ARV growth despite labour code cost Leave a ReplyCancel ReplyYour email address will not be published. Required fields are marked * Name * Email * Website Add Comment * Save my name, email, and website in this browser for the next time I comment.Post Comment
